Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 29, 2012	Oct. 01, 2011
Operating activities
Net income before noncontrolling interest	$ 167,289	$ 172,225
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Equity income of unconsolidated subsidiaries	(2,301)	(1,481)
Depreciation	48,590	49,079
Amortization	29,394	29,807
Deferred income taxes	4,039	4,445
Stock compensation	28,527	14,695
Excess tax benefits from stock-based compensation	(2,145)	(3,137)
Loss (gain) on sale of assets	(3,271)	702
Changes in assets and liabilities, net of effects of business acquisitions
Accounts and notes receivable	27,301	22,657
Inventories	(600)	15,633
Prepaid expenses and other current assets	(4,478)	(26,380)
Accounts payable	(30,673)	(45,759)
Employee compensation and benefits	(14,944)	(12,334)
Accrued product claims and warranties	2,220	115
Income taxes	(12,686)	18,045
Other current liabilities	47,414	46,924
Pension and post-retirement benefits	(20,062)	(23,636)
Other assets and liabilities	(16,263)	(21,041)
Net cash provided by (used for) operating activities	247,351	240,559
Investing activities
Capital expenditures	(49,942)	(53,063)
Proceeds from sale of property and equipment	5,130	139
Acquisitions, net of cash acquired	671,797	(733,105)
Other	(3,074)	(441)
Net cash provided by (used for) investing activities	623,911	(786,470)
Financing activities
Net short-term borrowings	(3,683)	24,772
Proceeds from long-term debt	500,860	1,370,423
Repayment of long-term debt	(723,443)	(771,793)
Debt issuance costs	(3,122)	(8,973)
Excess tax benefits from stock-based compensation	2,145	3,137
Stock issued to employees, net of shares withheld	21,972	11,788
Repurchases of common stock		(12,785)
Dividends paid	(66,153)	(59,669)
Net cash provided by (used for) financing activities	(271,424)	556,900
Effect of exchange rate changes on cash and cash equivalents	(7,345)	(4,380)
Change in cash and cash equivalents	592,493	6,609
Cash and cash equivalents, beginning of period	50,077	46,056
Cash and cash equivalents, end of period	$ 642,570	$ 52,665